Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Knox

Showing results (791-800 of 829) with videos related to

Pageof 83
Sort By:
Communications Biology|August 24, 2022
Egg-laying and locomotory screens with C. elegans yield a nematode-selective small molecule stimulator of neurotransmitter releaseSean Harrington, Jessica J Knox, Andrew R Burns, et al.
Molecular Cancer Therapeutics|June 11, 2020
Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer TypesJames T Topham, Emma Titmuss, Erin D Pleasance, et al.
Gastroenterology|February 1, 2021
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal AdenocarcinomaTalia Golan, Grainne M O'Kane, Robert E Denroche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Clinical and molecular correlates of circulating tumor fraction in patients with metastatic pancreatic ductal adenocarcinomaJames T Topham, Haley M Beckmann, Joanna M Karasinska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2020
Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular CharacteristicsJames T Topham, Joanna M Karasinska, Michael K C Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2020
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO GuidelineJohn D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?Erica S Tsang, James T Topham, Joanna M Karasinska, et al.
JAMA Oncology|September 6, 2019
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical TrialGhassan K Abou-Alfa, Qian Shi, Jennifer J Knox, et al.
NPJ Precision Oncology|April 4, 2025
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancerAbdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue, et al.
Iscience|August 12, 2025
Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinomaJames T Topham, Joanna M Karasinska, Andrew Metcalfe, et al.
Pageof 83

Showing results (791-800 of 829) with videos related to

Sort By:
Pageof 83
Communications Biology|August 24, 2022
Egg-laying and locomotory screens with C. elegans yield a nematode-selective small molecule stimulator of neurotransmitter releaseSean Harrington, Jessica J Knox, Andrew R Burns, et al.
Molecular Cancer Therapeutics|June 11, 2020
Endogenous Retrovirus Transcript Levels Are Associated with Immunogenic Signatures in Multiple Metastatic Cancer TypesJames T Topham, Emma Titmuss, Erin D Pleasance, et al.
Gastroenterology|February 1, 2021
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal AdenocarcinomaTalia Golan, Grainne M O'Kane, Robert E Denroche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Clinical and molecular correlates of circulating tumor fraction in patients with metastatic pancreatic ductal adenocarcinomaJames T Topham, Haley M Beckmann, Joanna M Karasinska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2020
Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular CharacteristicsJames T Topham, Joanna M Karasinska, Michael K C Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2020
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO GuidelineJohn D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?Erica S Tsang, James T Topham, Joanna M Karasinska, et al.
JAMA Oncology|September 6, 2019
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical TrialGhassan K Abou-Alfa, Qian Shi, Jennifer J Knox, et al.
NPJ Precision Oncology|April 4, 2025
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancerAbdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue, et al.
Iscience|August 12, 2025
Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinomaJames T Topham, Joanna M Karasinska, Andrew Metcalfe, et al.
Pageof 83